Retrial Of 1st AndroGel MDL Bellwether Case Nets Split Verdict, $3.2M Damages

(March 27, 2018, 9:47 AM EDT) -- CHICAGO — An Illinois federal court jury retrying the first AndroGel bellwether case on March 26 again issued a split verdict, finding in favor of defendant AbbVie Inc. on the claims of strict liability and fraudulent misrepresentation but in favor of plaintiff Jesse Mitchell for his claim of negligence and awarding him a total of $3.2 million in compensatory and punitive damages (In Re:  Testosterone Replacement Therapy Products Liability Litigation, MDL No. 2545, No. 14-1748, Jesse Mitchell v. AbbVie, No. 14-9178, N.D. Ill., Eastern Div.)....

Attached Documents

Related Sections